June 25 (SeeNews) - Dutch-registered livestock animal health company Huvepharma BV, owned by Bulgarian investor Kiril Domuschiev, said it has set a price range of between 20.00 euro and 25.75 euro per share for its planned initial public offering (IPO), seeking a valuation of up to 4.5 billion euro ($5.36 billion).